These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22291487)

  • 1. Lidocaine 5% patch for localized neuropathic pain: progress for the patient, a new approach for the physician.
    Hans G; Robert D; Verhulst J; Vercauteren M
    Clin Pharmacol; 2010; 2():65-70. PubMed ID: 22291487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of piroxicam patch compared to lidocaine patch for the treatment of postherpetic neuralgia.
    Kim JY; Lim HJ; Lee WJ; Lee SJ; Kim DW; Kim BS
    Ann Dermatol; 2011 May; 23(2):162-9. PubMed ID: 21747614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Topical pharmacologic approach with 5% lidocaine medicated plaster in the treatment of localized neuropathic pain].
    Provinciali L; Lattanzi S; Chiarlone R; Fogliardi A; Intelligente F; Irace C; Lanzilotta M; Palomba R; Storelli E; Zampi M
    Minerva Med; 2014 Dec; 105(6):515-27. PubMed ID: 25392960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profile of the capsaicin 8% patch for the management of neuropathic pain associated with postherpetic neuralgia: safety, efficacy, and patient acceptability.
    Laklouk M; Baranidharan G
    Patient Prefer Adherence; 2016; 10():1913-1918. PubMed ID: 27703336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of lidocaine 5% medicated plaster (VERSATIS®) in patients with localized neuropathic pain poorly responsive to pharmacological therapy.
    Martini A; Del Balzo G; Schweiger V; Zanzotti M; Picelli A; Parolini M; Chinellato E; Tamburin S; Polati E
    Minerva Med; 2018 Oct; 109(5):344-351. PubMed ID: 29856191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lidocaine patch for therapy of neuropathic and non-neuropathic pain. A clinical case series of 87 patients].
    Kern KU; Kohl M; Kiefer RT
    Nervenarzt; 2010 Dec; 81(12):1490-7. PubMed ID: 20577706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of lidocaine as a topical analgesic and improvements in patch delivery systems.
    Gudin J; Nalamachu S
    Postgrad Med; 2020 Jan; 132(1):28-36. PubMed ID: 31900074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical lidocaine for the treatment of postherpetic neuralgia.
    Khaliq W; Alam S; Puri N
    Cochrane Database Syst Rev; 2007 Apr; (2):CD004846. PubMed ID: 17443559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain Scale.
    Argoff CE; Galer BS; Jensen MP; Oleka N; Gammaitoni AR
    Curr Med Res Opin; 2004; 20 Suppl 2():S21-8. PubMed ID: 15563743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New analgesics for neuropathic pain: the lidocaine patch.
    Argoff CE
    Clin J Pain; 2000 Jun; 16(2 Suppl):S62-6. PubMed ID: 10870742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term treatment of neuropathic pain with a 5% lidocaine medicated plaster.
    Wilhelm IR; Tzabazis A; Likar R; Sittl R; Griessinger N
    Eur J Anaesthesiol; 2010 Feb; 27(2):169-73. PubMed ID: 20010108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical pain management with the 5% lidocaine medicated plaster--a review.
    Mick G; Correa-Illanes G
    Curr Med Res Opin; 2012 Jun; 28(6):937-51. PubMed ID: 22551228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of lidocaine patches for neuropathic pain in a comprehensive cancer centre.
    Fleming JA; O'Connor BD
    Pain Res Manag; 2009; 14(5):381-8. PubMed ID: 19862373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elucidation of pathophysiology and treatment of neuropathic pain.
    Vranken JH
    Cent Nerv Syst Agents Med Chem; 2012 Dec; 12(4):304-14. PubMed ID: 23033930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The topical 5% lidocaine medicated plaster in localized neuropathic pain: a reappraisal of the clinical evidence.
    de León-Casasola OA; Mayoral V
    J Pain Res; 2016; 9():67-79. PubMed ID: 26929664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of lidocaine patch 5% studies in the treatment of postherpetic neuralgia.
    Davies PS; Galer BS
    Drugs; 2004; 64(9):937-47. PubMed ID: 15101784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 5% Lidocaine-Medicated Plaster: Its Inclusion in International Treatment Guidelines for Treating Localized Neuropathic Pain, and Clinical Evidence Supporting its Use.
    Baron R; Allegri M; Correa-Illanes G; Hans G; Serpell M; Mick G; Mayoral V
    Pain Ther; 2016 Dec; 5(2):149-169. PubMed ID: 27822619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An open-label study of the lidocaine patch 5% in painful idiopathic sensory polyneuropathy.
    Herrmann DN; Barbano RL; Hart-Gouleau S; Pennella-Vaughan J; Dworkin RH
    Pain Med; 2005; 6(5):379-84. PubMed ID: 16266359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Tolerance of Lidocaine 5% Patches in Neuropathic Pain and Pain Related to Vaso-occlusive Sickle Cell Crises in Children: A Prospective Multicenter Clinical Study.
    Rousseau V; Morelle M; Arriuberge C; Darnis S; Chabaud S; Launay V; Thouvenin S; Roumenoff-Turcant F; Metzger S; Tourniaire B; Marec-Berard P
    Pain Pract; 2018 Jul; 18(6):788-797. PubMed ID: 29266772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a lidocaine patch in the management of postsurgical neuropathic pain in patients with cancer: a phase III double-blind crossover study (N01CB).
    Cheville AL; Sloan JA; Northfelt DW; Jillella AP; Wong GY; Bearden Iii JD; Liu H; Schaefer PL; Marchello BT; Christensen BJ; Loprinzi CL
    Support Care Cancer; 2009 Apr; 17(4):451-60. PubMed ID: 19142669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.